We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.2B
AUM Growth
+$42.9M
Cap. Flow
-$201M
Cap. Flow %
-1.65%
Top 10 Hldgs %
32.14%
Holding
3,019
New
19
Increased
384
Reduced
1,106
Closed
31

Top Buys

Rank Stock Value
1
APO icon
Apollo Global Management
APO
+$9.91M
2
WDAY icon
Workday
WDAY
+$7.67M
3
DOCU
DocuSign
DOCU
+$6.86M
4
FLEX icon
Flex
FLEX
+$6.08M
5
WMT icon
Walmart Inc
WMT
+$4.41M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$17.3M
2
AAPL icon
Apple
AAPL
+$15.6M
3
AVGO icon
Broadcom
AVGO
+$10.7M
4
MSFT icon
Microsoft
MSFT
+$9.46M
5
META icon
Meta Platforms (Facebook)
META
+$8.88M

Sector Composition

Rank Sector Weight
1 Technology 30.87%
2 Financials 13.55%
3 Consumer Discretionary 11.99%
4 Healthcare 9.95%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOCO
2901
DELISTED
GoHealth
GOCO
$2K ﹤0.01%
133
– –
HLVX
2902
DELISTED
HilleVax
HLVX
$2K ﹤0.01%
891
– –
HOWL icon
2903
Werewolf Therapeutics
HOWL
$22.4M
$2K ﹤0.01%
1,055
– –
IGMS
2904
DELISTED
IGM Biosciences
IGMS
$2K ﹤0.01%
351
– –
INMB icon
2905
INmune Bio
INMB
$44.9M
$2K ﹤0.01%
422
– –
INNV icon
2906
InnovAge Holding
INNV
$1.56B
$2K ﹤0.01%
631
– –
INO icon
2907
Inovio Pharmaceuticals
INO
$85.6M
$2K ﹤0.01%
879
– –
LCTX icon
2908
Lineage Cell Therapeutics
LCTX
$264M
$2K ﹤0.01%
4,351
– –
LXRX icon
2909
Lexicon Pharmaceuticals
LXRX
$1.03B
$2K ﹤0.01%
2,409
– –
MASS icon
2910
908 Devices
MASS
$312M
$2K ﹤0.01%
766
– –
METCB icon
2911
Ramaco Resources Class B
METCB
$423M
$2K ﹤0.01%
178
+10
+6% +$97
NL icon
2912
NLI Holdings
NL
$289M
$2K ﹤0.01%
288
– –
NOTE
2913
DELISTED
FiscalNote
NOTE
$2K ﹤0.01%
175
– –
OBIO icon
2914
Orchestra BioMed
OBIO
$228M
$2K ﹤0.01%
512
– –
OVID icon
2915
Ovid Therapeutics
OVID
$427M
$2K ﹤0.01%
2,011
– –
PRPL icon
2916
Purple Innovation
PRPL
$34.5M
$2K ﹤0.01%
80
– –
RNAC icon
2917
Cartesian Therapeutics
RNAC
$218M
$2K ﹤0.01%
130
– –
STKS icon
2918
The ONE Group
STKS
$55.9M
$2K ﹤0.01%
723
– –
STRW icon
2919
Strawberry Fields REIT
STRW
$195M
$2K ﹤0.01%
202
– –
STTK icon
2920
Shattuck Labs
STTK
$646M
$2K ﹤0.01%
1,353
– –
SWKH
2921
DELISTED
SWK Holdings
SWKH
$2K ﹤0.01%
154
– –
TNYA icon
2922
Tenaya Therapeutics
TNYA
$160M
$2K ﹤0.01%
1,587
– –
TPIC
2923
DELISTED
TPI Composites
TPIC
$2K ﹤0.01%
1,262
– –
TUSK icon
2924
Mammoth Energy Services
TUSK
$122M
$2K ﹤0.01%
785
– –
VALU icon
2925
Value Line
VALU
$333M
$2K ﹤0.01%
33
– –
115 116
117
118 119

Similar funds

Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return

Amalgamated Bank's Q4 2024 Portfolio in Review

As of Q4 2024, Amalgamated Bank held 3,019 positions worth $12.2B, up 0.35% from $12.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 1.7%. Amalgamated Bank opened 19 new positions and exited 31, leaving the 3,019-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Amalgamated Bank's largest Q4 2024 buy was Flex: 164,217 shares worth $6.3M.
  • Amalgamated Bank added most to Apollo Global Management in Q4 2024, an estimated $9.91M increase.
  • Amalgamated Bank's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $17.3M.
  • Amalgamated Bank fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $2.94M.
  • Amalgamated Bank's ten largest holdings make up 32% of its $12.2B portfolio in Q4 2024.
  • Amalgamated Bank opened 19 new positions and closed 31 in Q4 2024.
  • Amalgamated Bank's portfolio value rose 0.35% quarter-over-quarter to $12.2B.

Based on Amalgamated Bank's 13F filing for Q4 2024, filed 4 Feb 2025.